Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Urogynecology (Philadelphia, Pa.)
|
March 19, 2025
Activity Restrictions After Midurethral Sling: A Randomized Controlled Trial
Pedro Alvarez, Cem Demirkiran, Leslie Rickey, et al.
Clinical Imaging
|
January 24, 2021
Effects of iron oxide particles on MRI and mammography in breast cancer patients after a sentinel lymph node biopsy with paramagnetic tracers
Erkin Aribal, Levent Çelik, Cem Yilmaz, et al.
Cureus
|
November 19, 2025
Successful Sequential Use of the Antibody-Drug Conjugate Trastuzumab Deruxtecan After Progression on Sacituzumab Govitecan in a Recurrent Treatment-Resistant Ovarian Cancer Patient: A Case Report
Victoria M Ettorre, Michelle Greenman, Luca Palmieri, et al.
Gynecologic Oncology Reports
|
June 16, 2023
Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
Blair McNamara, Stefania Bellone, Cem Demirkiran, et al.
Gynecologic Oncology Reports
|
August 7, 2024
Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer
Michelle Greenman, Stefania Bellone, Cem Demirkiran, et al.
Gynecologic Oncology Reports
|
June 16, 2023
Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy
Blair McNamara, Stefania Bellone, Cem Demirkiran, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
October 13, 2020
Perioperative, postoperative and anatomical outcomes of robotic sacrocolpopexy
Gokhan Sami Kilic, Toy Lee, Kelsey Lewis, et al.
International Journal of Molecular Sciences
|
February 10, 2024
Mitochondrial Unfolded Protein Response Gene <i>Clpp</i> Is Required for Oocyte Function and Female Fertility
Yagmur Ergun, Aysegul Gizem Imamoglu, Mauro Cozzolino, et al.
Gynecologic Oncology Reports
|
June 29, 2026
Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical study
Sarah Ottum, Orazio De Tommasi, Cem Demirkiran, et al.
Gynecologic Oncology
|
September 4, 2025
Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenografts
Victoria M Ettorre, Cem Demirkiran, Stefania Bellone, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Urogynecology (Philadelphia, Pa.)
|
March 19, 2025
Activity Restrictions After Midurethral Sling: A Randomized Controlled Trial
Pedro Alvarez, Cem Demirkiran, Leslie Rickey, et al.
Clinical Imaging
|
January 24, 2021
Effects of iron oxide particles on MRI and mammography in breast cancer patients after a sentinel lymph node biopsy with paramagnetic tracers
Erkin Aribal, Levent Çelik, Cem Yilmaz, et al.
Cureus
|
November 19, 2025
Successful Sequential Use of the Antibody-Drug Conjugate Trastuzumab Deruxtecan After Progression on Sacituzumab Govitecan in a Recurrent Treatment-Resistant Ovarian Cancer Patient: A Case Report
Victoria M Ettorre, Michelle Greenman, Luca Palmieri, et al.
Gynecologic Oncology Reports
|
June 16, 2023
Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
Blair McNamara, Stefania Bellone, Cem Demirkiran, et al.
Gynecologic Oncology Reports
|
August 7, 2024
Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer
Michelle Greenman, Stefania Bellone, Cem Demirkiran, et al.
Gynecologic Oncology Reports
|
June 16, 2023
Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy
Blair McNamara, Stefania Bellone, Cem Demirkiran, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
October 13, 2020
Perioperative, postoperative and anatomical outcomes of robotic sacrocolpopexy
Gokhan Sami Kilic, Toy Lee, Kelsey Lewis, et al.
International Journal of Molecular Sciences
|
February 10, 2024
Mitochondrial Unfolded Protein Response Gene <i>Clpp</i> Is Required for Oocyte Function and Female Fertility
Yagmur Ergun, Aysegul Gizem Imamoglu, Mauro Cozzolino, et al.
Gynecologic Oncology Reports
|
June 29, 2026
Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical study
Sarah Ottum, Orazio De Tommasi, Cem Demirkiran, et al.
Gynecologic Oncology
|
September 4, 2025
Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenografts
Victoria M Ettorre, Cem Demirkiran, Stefania Bellone, et al.
Page
of 4